0

Journal Articles

in Surgical Oncology
 101-120 of 361 Articles
Invited Critique |  February 01, 2011
Injection Site Mass Following Sentinel Node Biopsy for Breast Cancer:  Comment on “Occurrence of Prolonged Injection Site Mass With Methylene Blue but Not Isosulfan Blue After Sentinel Node Procedure”
Kirby I. Bland, MD
Arch Surg. 2011;146(2):142. doi:10.1001/archsurg.2010.322.
Special Feature |  February 01, 2011 FREE
Image of the Month—Quiz Case
Dharmesh Kaswala, MD; Nitin Patel, MD; Sushil Ahlawat, MD
Arch Surg. 2011;146(2):235. doi:10.1001/archsurg.2010.341-a.
Special Feature |  February 01, 2011 FREE
Image of the Month—Diagnosis
Arch Surg. 2011;146(2):238. doi:10.1001/archsurg.2010.339-b.
Invited Critique |  January 01, 2011
Primum Non Nocere, or Leave That Ostomy Alone:  Comment on “Incisional Hernias in Temporary Stoma Wounds”
Chandrakanth Are, MD; Quan Ly, MD; Aaron R. Sasson, MD
Arch Surg. 2011;146(1):99-100. doi:10.1001/archsurg.2010.282.
Invited Critique |  January 01, 2011
AFP in OLT for HCC?: Another Shadow on the Cave Wall:  Comment on “Evaluation of Absolute Serum α-Fetoprotein Levels in Liver Transplant for Hepatocellular Cancer”
Andrew M. Cameron, MD, PhD
Arch Surg. 2011;146(1):33-34. doi:10.1001/archsurg.2010.280.
Original Article |  January 01, 2011 FREE
Single-Port Laparoscopic Sphincter-Saving Mesorectal Excision for Rectal Cancer:  Report of the First 4 Human Cases
Ismail Hamzaoglu, MD; Tayfun Karahasanoglu, MD; Bilgi Baca, MD; et al.
Arch Surg. 2011;146(1):75-81. doi:10.1001/archsurg.2010.300.
Original Article |  January 01, 2011 FREE
Evaluation of Absolute Serum α-Fetoprotein Levels in Liver Transplant for Hepatocellular Cancer
Brian Mailey, MD; Avo Artinyan, MD, MS; Joshua Khalili, BS; et al.
Arch Surg. 2011;146(1):26-33. doi:10.1001/archsurg.2010.295.
Invited Critique |  November 15, 2010
Does Surgeon Volume Matter for Gastric Cancer Surgery?:  Comment on “Surgeon Subspecialty as a Factor in Improving Long-term Outcomes for Gastric Cancer”
Vivian E. Strong, MD
Arch Surg. 2010;145(11):1096-1097. doi:10.1001/archsurg.2010.224.
Invited Critique |  November 15, 2010
The Maximally Invasive Hepatobiliary Surgeon: A Dying Breed?:  Comment on “Laparoscopic vs Open Hepatectomy for Benign and Malignant Tumors”
Eric H. Jensen, MD; Selwyn M. Vickers, MD
Arch Surg. 2010;145(11):1118. doi:10.1001/archsurg.2010.234.
Original Article |  November 15, 2010 FREE
Surgeon Subspecialty as a Factor in Improving Long-term Outcomes for Gastric Cancer:  Twenty Years of Experience in Korea
You-Jin Jang, MD; Man Sik Park, PhD; Sung-Soo Park, MD, PhD; et al.
Arch Surg. 2010;145(11):1091-1096. doi:10.1001/archsurg.2010.232.
Original Article |  November 15, 2010 FREE
Risk Factors for Invasive Breast Cancer When Core Needle Biopsy Shows Ductal Carcinoma In Situ
Emil D. Kurniawan, BMedSc; Allison Rose, MBBS, FRANZCR, MMed; Arlene Mou, MBBS, FRANZCR; et al.
Arch Surg. 2010;145(11):1098-1104. doi:10.1001/archsurg.2010.243.
Review Article |  November 15, 2010 FREE
Laparoscopic vs Open Hepatic Resection for Benign and Malignant Tumors:  An Updated Meta-analysis
Arch Surg. 2010;145(11):1109-1118. doi:10.1001/archsurg.2010.227.
Correspondence |  October 01, 2010
Micrometastasis and Axillary Dissection in Breast Cancer
M. Badruddoja, MD, MS, FRCS, FRACS
Arch Surg. 2010;145(10):1022-1023. doi:10.1001/archsurg.2010.214.
Correspondence |  October 01, 2010
Micrometastasis and Axillary Dissection in Breast Cancer—Reply
Nabil Wasif, MD; Armando Giuliano, MD
Arch Surg. 2010;145(10):1023. doi:10.1001/archsurg.2010.215.
Commentary |  September 01, 2010
Extralevator Abdominoperineal Resection for Low Rectal Cancer:  New Direction or Miles Behind?
Des C. Winter, MD, FRCSI
Arch Surg. 2010;145(9):811-813. doi:10.1001/archsurg.2010.174.
Special Feature |  September 01, 2010 FREE
Image of the Month—Quiz Case
Faith Dorsey, MD; Melissa W. Taggart, MD; William E. Fisher, MD
Arch Surg. 2010;145(9):913. doi:10.1001/archsurg.2010.172-a.
Paper |  September 01, 2010 FREE
Preoperative Tattooing and Improved Lymph Node Retrieval Rates From Colectomy Specimens in Patients With Colorectal Cancers
Katie Dawson, MD; Abigail Wiebusch, MD; Richard C. Thirlby, MD
Arch Surg. 2010;145(9):826-830. doi:10.1001/archsurg.2010.180.
Correspondence |  August 01, 2010
Is Laparoscopic Surgery for Early Gallbladder Cancer Less Invasive or Dangerous?
Tetsuji Fujita, MD
Arch Surg. 2010;145(8):797-798. doi:10.1001/archsurg.2010.135.
Correspondence |  August 01, 2010
Is Laparoscopic Surgery for Early Gallbladder Cancer Less Invasive or Dangerous?—Reply
Jai Young Cho, MD, PhD; Ho-Seong Han, MD, PhD; Yoo-Seok Yoon, MD, PhD; et al.
Arch Surg. 2010;145(8):798-799. doi:10.1001/archsurg.2010.136.
Special Feature |  July 01, 2010 FREE
Image of the Month—Quiz Case
Trang K. Nguyen, MD; Barish H. Edil, MD
Arch Surg. 2010;145(7):703. doi:10.1001/archsurg.2010.121-a.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  May 20, 2013
Comparative Effectiveness of Intensity-Modulated Radiotherapy and Conventional Conformal Radiotherapy in the Treatment of Prostate Cancer After Radical Prostatectomy
Gregg H. Goldin, MD; Nathan C. Sheets, MD; Anne-Marie Meyer, PhD; et al.
JAMA Internal Medicine
Invited Commentary  |  May 20, 2013
Expanding Utilization of Intensity-Modulated Radiotherapy for Prostate Cancer:  Comment on “Comparative Effectiveness of Intensity-Modulated Radiotherapy and Conventional Conformal Radiotherapy in the Treatment of Prostate Cancer After Radical Prostatectomy”
Matthew R. Cooperberg, MD, MPH
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  April 10, 2013
Transoral Robotic Surgery for Oropharyngeal Cancer:  Long-term Quality of Life and Functional Outcomes
Peter T. Dziegielewski, MD, FRCSC; Theodoros N. Teknos, MD; Kasim Durmus, MD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Invited Commentary  |  April 10, 2013
Improved Quality of Life and Function After Oropharyngeal Cancer Treatment
William M. Lydiatt, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems